Detalles de la búsqueda
1.
Copper-Catalyzed Enantioselective Doyle-Kirmse Reaction of Azide-Ynamides via α-Imino Copper Carbenes.
Angew Chem Int Ed Engl
; 62(10): e202216923, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36639865
2.
Construction of Axially Chiral Arylpyrroles via Atroposelective Diyne Cyclization.
Angew Chem Int Ed Engl
; 62(23): e202303670, 2023 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996038
3.
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.
Cancer
; 125(13): 2185-2193, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892700
4.
Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis.
Breast Cancer Res Treat
; 161(2): 259-267, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27885439
5.
Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Ann Surg Oncol
; 21(1): 42-50, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24013900
6.
Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule.
Oncologist
; 18(5): 511-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23635560
7.
Copper-catalyzed intermolecular formal (5 + 1) annulation of 1,5-diynes with 1,2,5-oxadiazoles.
Commun Chem
; 6(1): 194, 2023 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700020
8.
Association of HER-2 copy number and HER-2/CEP-17 ratio with neoadjuvant taxane-containing chemotherapy sensitivity in locally advanced breast cancer.
Oncologist
; 17(6): 792-800, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22561335
9.
Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer.
Ann Surg Oncol
; 19(9): 3002-11, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22437200
10.
A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer.
J Surg Oncol
; 105(6): 577-85, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22065549
11.
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Clin Cancer Res
; 28(13): 2807-2817, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35247906
12.
[Effect of postoperative pregnancy upon prognosis of young breast cancer patients].
Zhonghua Yi Xue Za Zhi
; 89(44): 3126-9, 2009 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-20193275
13.
[Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer].
Zhonghua Wai Ke Za Zhi
; 47(7): 511-5, 2009 Apr 01.
Artículo
en Zh
| MEDLINE | ID: mdl-19595208
14.
Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
Anticancer Res
; 28(5B): 3093-7, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19031963
15.
[A study on the relationship between breast cancer molecular classification and prognosis].
Zhonghua Wai Ke Za Zhi
; 46(18): 1400-3, 2008 Sep 15.
Artículo
en Zh
| MEDLINE | ID: mdl-19094512
16.
[Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy].
Zhonghua Wai Ke Za Zhi
; 44(19): 1322-4, 2006 Oct 01.
Artículo
en Zh
| MEDLINE | ID: mdl-17217817
17.
[A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].
Zhonghua Wai Ke Za Zhi
; 44(11): 745-7, 2006 Jun 01.
Artículo
en Zh
| MEDLINE | ID: mdl-16836921
18.
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.
Oncotarget
; 6(20): 18174-82, 2015 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26053183
19.
ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
PLoS One
; 9(12): e114646, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25504233
20.
Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer.
PLoS One
; 7(7): e41380, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22848477